Comparison of patients using β-blockers versus patients using other BPLMs only from the CPRD and DIN studies: pooled HRs (95% CI) from meta-analyses of cancer site-specific results
| Comparison (vs controls) | CPRD | DIN | p Value† |
|---|---|---|---|
| All patients using β-blockers | 1.01 (0.91 to 1.13) | 1.18 (1.04 to 1.33)** | 0.06 |
| Patients using β-blockers only | 0.94 (0.82 to 1.07) | 1.37 (1.16 to 1.61)*** | <0.001*** |
| β-Blockers and other BPLM | 1.06 (0.95 to 1.19) | 1.11 (0.91 to 1.34) | 0.69 |
| Non-selective β-blockers only | 0.96 (0.8 to 1.15) | 1.21 (0.94 to 1.55) | 0.14 |
**p<0.01; ***p<0.001.
†Wald tests of CPRD vs DIN HRs.
BPLMs, blood pressure lowering medicines; CPRD, Clinical Practice Research Datalink; DIN, Doctors’ Independent Network.